FDA inspection

Ipsen BioPharm Ltd: FDA inspection ending Apr 26, 2019

FDA inspection 1117834 · Voluntary Action Indicated (VAI) · Wrexham

Key facts

Inspection ID 1117834
Firm Ipsen BioPharm Ltd
FEI number 1000346340
Address Unit 418, Ash Road North
City Wrexham
Country United Kingdom
Fiscal year 2019
Inspection end date Apr 26, 2019
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections